AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
MBOT vs AMZN Fundamental Comparison
| Metric | MBOT | AMZN |
|---|---|---|
| Revenue | $2,000.0 | $716.9B |
| Net Income | $-13.1M | $77.7B |
| Net Margin | -657,100.0% | 10.8% |
| ROE | -16.9% | 18.9% |
| ROA | -16.1% | 9.5% |
| Current Ratio | 23.33x | 1.05x |
| Debt/Equity | 0.03x | 0.17x |
| EPS | $-0.29 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MBOT vs AMZN: Frequently Asked Questions
Is MBOT or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. MBOT is rated STRONG SELL (95% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does MBOT compare to AMZN fundamentally?
Microbot Medical Inc. has ROE of -16.9% vs AMAZON COM INC's 18.9%. Net margins are -657,100.0% vs 10.8% respectively.
Which stock pays higher dividends, MBOT or AMZN?
MBOT has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MBOT or AMZN for long term?
For long-term investing, consider that MBOT has STRONG SELL rating with 95% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MBOT vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MBOT vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.